Mihael Hristos Polymeropoulos, President and CEO at Vanda Pharmaceuticals Inc. (VNDA), sold 74,192 shares at $11.19 ($828K) on 2022-03-01, disclosed to the SEC on 2022-03-02.
Seasonal sale ($828k) by President and CEO — this insider has traded VNDA in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.19 | 7,508 | $84K | 10.1% |
| 2 | $11.19 | 7,508 | $84K | 10.1% |
| 3 | $11.15 | 29,588 | $330K | 39.9% |
| 4 | $11.15 | 29,588 | $330K | 39.9% |
| Total | $11.16 avg | 74,192 | $828K | 100% |
| Filing → |
| VNDA | BUY | 2025-05-21 | $44K | — | Filing → |
| VNDA | BUY | 2025-05-19 | $84K | — | Filing → |
| VNDA | BUY | 2025-03-06 | $50K | — | Filing → |